Balance Sheet for ADMA Biologics Inc (ADMA)

$ 3.29   0.43 (+15.03%) Volume: 10.76m 4:00 PM EDT 29-May-2020
After Hours:  $ 3.34   0.05 (+1.52%) Volume: 99.32k 7:59 PM EDT 29-May-2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 26,752 22,755 43,108 9,915 10,441
Restrictable Cash - - 1,500 - -
Marketable Securities - - 245 5,390 6,368
Accounts Receivable 3,470 1,392 3,880 1,018 924
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 3,470 1,392 3,880 1,018 924
Inventories, Raw Materials 33,382 14,020 10,143 5,020 -
Inventories, Work in Progress 14,456 - 1,265 - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 5,227 4,597 1,220 - -
Inventories, Other 53,065 18,616 12,628 5,020 3,446
Inventories, Adjustments & Allowances - - - - -
Inventories 53,065 18,616 12,628 5,020 3,446
Prepaid Expenses 2,534 1,766 1,226 314 111
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 85,820 44,530 62,342 21,657 21,290
Land and Improvements 4,339 4,339 4,339 - -
Buildings and Improvement 17,737 17,346 17,303 2,699 2,690
Machinery, Furniture and Equipment 11,104 11,006 9,372 1,525 1,460
Construction in Progress 4,286 846 738 - -
Fixed Assets, Other - - - - -
Fixed Assets, Total 37,466 33,537 31,753 4,224 4,151
Gross Fixed Assets 37,466 33,537 31,753 4,224 4,151
Accumulated Depreciation (5,725) (3,421) (1,286) (2,223) (1,754)
Net Fixed Assets 31,741 30,116 30,467 2,001 2,397
Intangibles 3,159 4,004 4,849 - -
Cost in Excess 3,530 3,530 3,530 - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - 5,154 5,496 27 27
Total Non-Current Assets 41,270 44,347 45,677 2,028 2,424
Total Assets 127,091 88,877 108,019 23,685 23,715
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 9,175 5,900 5,921 2,565 2,088
Short Term Debt 229 30 17 - 15
Notes Payable - - 13,333 6,111 -
Accrued Expenses 4,481 3,552 3,376 2,385 1,968
Accrued Liabilities 4,481 3,552 3,376 2,385 1,968
Deferred Revenues 143 143 143 145 145
Current Deferred Income Taxes - - - - -
Other Current Liabilities - - (13,350) 17 -
Total Current Liabilities 14,028 9,625 9,440 11,223 4,217
Long Term Debt 83,199 44,075 42,971 14,112 15,715
Deferred Income Tax 2,262 2,404 2,547 2,690 2,962
Other Non-Current Liabilities 2,368 15,287 15,275 2,788 2,962
Minority Interest - - - - -
Capital Lease Obligations 1,302 119 - 20 36
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 86,870 59,481 58,246 16,919 18,677
Total Liabilities 100,898 69,106 67,686 28,142 22,894
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 26,193 19,770 40,333 (4,457) 821
Common Par 6 5 5 1 1
Additional Paid in Capital 290,904 236,203 191,022 102,476 88,240
Cumulative Translation Adjustments - - - - -
Retained Earnings (264,717) (216,437) (150,694) (106,935) (87,420)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 109,392 63,845 83,304 9,654 16,500
Total Equity 26,193 19,770 40,333 (4,457) 821
Total Liabilities & Shareholder's Equity 127,091 88,877 108,019 23,685 23,715
Cash Flow (48,279) (65,743) (46,344) (20,519) (18,706)
Working Capital 71,792 34,905 52,901 10,434 17,074
Free Cash Flow (80,005) (64,774) (39,948) (18,342) (15,444)
Invested Capital 109,392 63,845 83,304 9,654 16,500
Shares Outstanding - Common Class Only 59,318 46,353 45,317 12,887 10,713
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 59,318 46,353 45,317 12,887 10,713
Total Common Shares Outstanding 59,318 46,353 45,317 12,887 10,713
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 54,348 45,189 22,896 12,153 10,412
Diluted Weighted Shares Outstanding 54,348 45,189 22,896 12,153 10,412